OncoVerity, Inc. — Form D
OncoVerity, Inc. of Aurora, CO, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-10. The offering totals $42.0M, of which $14.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-12-10
- Form: D
- Accession: 0001123292-24-000385
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $42.0M
- Amount sold: $14.0M
- Remaining: $28.0M
- Investors: 2
- Date of first sale: 2024-11-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-531662
Issuer
- Name: OncoVerity, Inc.
- CIK: 0001943593
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 12635 E Montview Blvd., Aurora, CO, 80045
- Phone: 720-859-4105
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Massimiliano Colao | Director | Aurora, CO |
| Steven Hess | Director | Glendale, CO |
| Arjen Lemmen | Director | Aurora, CO |
| Kimberly Muller | Director | Aurora, CO |
| Petra Van Vlierberghe | Director | Aurora, CO |
| Massimiliano Colao | Executive Officer | Aurora, CO |
| Clayton Smith | Executive Officer | Aurora, CO |
| Steven VanNurden | Director | Aurora, CO |
| Steven VanNurden | Executive Officer | Aurora, CO |
Other filings by this issuer (1)
More